Toggle Main Menu Toggle Search

Open Access padlockePrints

Cross-sectional analysis of variation in diagnosis of Lewy body dementia in three English regions: data from the DETERMIND programme

Lookup NU author(s): Dr Calum HamiltonORCiD, Professor Alan ThomasORCiD, Dr Paul DonaghyORCiD, Christian Mueller

Downloads


Licence

This work is licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0).


Abstract

Objectives We aimed to examine regional differences in the relationship between core clinical features assessed using the Improving the DIAgnosis and Management Of Neurodegenerative Dementias of Lewy body type in the NHS (DIAMOND-Lewy) dementia with Lewy bodies (DLB) Assessment Toolkit and memory service diagnoses of Lewy body dementia (LBD).Design Secondary analysis of a multicentre observational study.Setting Memory clinics in three sites across England (North East, London and South East) from July 2019 to March 2023.Participants 935 individuals with a new memory service diagnosis of dementia enrolled in the DETERMinants of quality of life, care and costs, and consequences of INequalities in people with Dementia and their carers (DETERMIND) programme.Outcome measures Core clinical features of DLB were assessed using the DLB Assessment Toolkit. The relationship between core clinical features and memory service diagnosis of LBD was examined using Bayesian probit models.Results There were higher rates of LBD diagnosis from memory services in the cohort in North East England compared with the London and South East centres (11% vs 4%; risk ratio (RR)=1.72 (1.35–2.08)) and evidence of a regional moderating effect on the relationship between clinical features and LBD diagnosis (RR=1.73 (1.26–2.40)).All core clinical features of DLB were associated with LBD diagnosis in North East England, whereas visual hallucinations were the most influential diagnostic feature in London and the South East (RR=3.18 (2.29–4.02)).Conclusions Regional differences in LBD diagnosis in UK memory services appear to reflect different rates of recognition of specific LBD clinical features. Routinely using a standardised DLB Assessment Toolkit and improving awareness of non-hallucination features in LBD could help to address this disparity.


Publication metadata

Author(s): Hamilton CA, Thomas AJ, Donaghy PC, Hicks B, Mueller C, Banerjee C

Publication type: Article

Publication status: Published

Journal: BMJ Open

Year: 2026

Volume: 16

Issue: 7

Online publication date: 22/07/2026

Acceptance date: 09/07/2026

Date deposited: 22/07/2026

ISSN (print): 2044-6055

ISSN (electronic): 2044-6055

Publisher: BMJ Group

URL: https://doi.org/10.1136/bmjopen-2026-121991

DOI: 10.1136/bmjopen-2026-121991

Data Access Statement: Data are available upon reasonable request. Direct access will be granted to authorised representatives from the sponsor and host institution or via request to the study CI Professor SB ( sube.banerjee@nottingham.ac.uk). Following the end of the study in January 2027, anonymised data will be uploaded to the UK Data Archive online repository. Access to data will be limited to authorised researchers who agree to the End User License http://dataarchive.ac.uk/conditions).


Altmetrics

Altmetrics provided by Altmetric


Funding

Funder referenceFunder name
Economic and Social Research Council (UK)
Medical Research Council (grant number MR/W000229/1)
National Institute for Health Research (UK) through grant number ES/S010351/1
NIHR Maudsley Biomedical Research Centre

Share